Wertpapierdatensatz · archiviertes Quartal
LLY
Eli Lilly and Company · Healthcare · Drug Manufacturers - General
193Erfasste Halter
+2Δ Inhaber
707.04MGehaltene Aktien
$758.81BGemeldeter Wert
+3Neue Positionen
−0Ausstiege
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +1.0% ·
Aktienfluss -0.6% ·
neue Nettopositionen +1.6%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 193 | +4 | 671.92M | $804.91B | +6 | −1 |
| Q1 2026 | 191 | -3 | 666.59M | $613.20B | +1 | −5 |
| Q4 2025 | 193 | +2 | 707.04M | $758.81B | +3 | — |
| Q3 2025 | 27 | -3 | 329.88M | $251.63B | +2 | −6 |
| Q2 2025 | 28 | -1 | 307.45M | $239.60B | +2 | −3 |
| Q1 2025 | 26 | 0 | 140.32M | $115.83B | +1 | −1 |
| Q4 2024 | 26 | +1 | 145.00M | $111.91B | +3 | −2 |
| Q3 2024 | 24 | +2 | 109.89M | $97.29B | +2 | — |
| Q2 2024 | 22 | — | 112.43M | $101.75B | — | — |
Wer es hält · Q4 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Lilly Endowment Inc | 92.19M | — | $99.08B | 100.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passiv) | 81.97M | +1.2% | $88.09B | 1.3% | ▲ Add | 3 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passiv) | 81.97M | +1.2% | $88.09B | 1.3% | ▲ Add | 3 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passiv) | 81.97M | +1.2% | $88.09B | 1.3% | ▲ Add | 3 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passiv) | 81.97M | +1.2% | $88.09B | 1.3% | ▲ Add | 3 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passiv) | 81.97M | +1.2% | $88.09B | 1.3% | ▲ Add | 3 | SEC ↗ |
| 7 | The Vanguard Group ✦ (passiv) | 81.97M | +1.2% | $88.09B | 1.3% | ▲ Add | 3 | SEC ↗ |
| 8 | The Vanguard Group ✦ (passiv) | 81.97M | +1.2% | $88.09B | 1.3% | ▲ Add | 3 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 14 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 15 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 16 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 17 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 18 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 19 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 20 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 21 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 22 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 23 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 24 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 25 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 26 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 27 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 28 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 29 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 30 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 31 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 32 | BlackRock ✦ (passiv) | 66.79M | +1.5% | $71.78B | 1.2% | ▲ Add | 3 | SEC ↗ |
| 33 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 34 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 35 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 36 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 37 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 38 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 39 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 40 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 41 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 42 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 43 | Pnc Financial Services Group, Inc. | 51.33M | — | $55.17B | 30.1% | n/c | 1 | SEC ↗ |
| 44 | State Street Global Advisors ✦ (passiv) | 35.36M | +1.8% | $38.00B | 1.3% | ▲ Add | 5 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 25.72M | +6.4% | $27.64B | 1.4% | ▲ Add | 3 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 25.72M | +6.4% | $27.64B | 1.4% | ▲ Add | 3 | SEC ↗ |
| 47 | Fidelity (FMR) ✦ | 25.72M | +6.4% | $27.64B | 1.4% | ▲ Add | 3 | SEC ↗ |
| 48 | Fidelity (FMR) ✦ | 25.72M | +6.4% | $27.64B | 1.4% | ▲ Add | 3 | SEC ↗ |
| 49 | Fidelity (FMR) ✦ | 25.72M | +6.4% | $27.64B | 1.4% | ▲ Add | 3 | SEC ↗ |
| 50 | Fidelity (FMR) ✦ | 25.72M | +6.4% | $27.64B | 1.4% | ▲ Add | 3 | SEC ↗ |
| 51 | Capital Research Global Investors | 24.57M | — | $26.40B | 4.9% | n/c | 1 | SEC ↗ |
| 52 | Geode Capital Management ✦ (passiv) | 19.81M | 0.0% | $21.22B | 1.3% | ▼ Trim | 7 | SEC ↗ |
| 53 | Geode Capital Management ✦ (passiv) | 19.81M | 0.0% | $21.22B | 1.3% | ▼ Trim | 7 | SEC ↗ |
| 54 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 55 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 56 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 57 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 58 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 59 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 60 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 61 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 62 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 63 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 64 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 65 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 66 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 67 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 68 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 69 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 70 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 71 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 72 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 73 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 74 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 75 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 76 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 77 | Morgan Stanley ✦ | 15.59M | +2.7% | $16.76B | 1.0% | ▲ Add | 2 | SEC ↗ |
| 78 | Capital World Investors ✦ | 15.03M | +0.4% | $16.15B | 2.2% | ▲ Add | 7 | SEC ↗ |
| 79 | T. Rowe Price ✦ | 14.91M | +10.6% | $16.02B | 1.7% | ▲ Add | 7 | SEC ↗ |
| 80 | T. Rowe Price ✦ | 14.91M | +10.6% | $16.02B | 1.7% | ▲ Add | 7 | SEC ↗ |
| 81 | Wellington Management ✦ | 13.36M | -8.3% | $14.35B | 2.5% | ▼ Trim | 7 | SEC ↗ |
| 82 | Wellington Management ✦ | 13.36M | -8.3% | $14.35B | 2.5% | ▼ Trim | 7 | SEC ↗ |
| 83 | Wellington Management ✦ | 13.36M | -8.3% | $14.35B | 2.5% | ▼ Trim | 7 | SEC ↗ |
| 84 | Wellington Management ✦ | 13.36M | -8.3% | $14.35B | 2.5% | ▼ Trim | 7 | SEC ↗ |
| 85 | Wellington Management ✦ | 13.36M | -8.3% | $14.35B | 2.5% | ▼ Trim | 7 | SEC ↗ |
| 86 | Wellington Management ✦ | 13.36M | -8.3% | $14.35B | 2.5% | ▼ Trim | 7 | SEC ↗ |
| 87 | Wellington Management ✦ | 13.36M | -8.3% | $14.35B | 2.5% | ▼ Trim | 7 | SEC ↗ |
| 88 | Wellington Management ✦ | 13.36M | -8.3% | $14.35B | 2.5% | ▼ Trim | 7 | SEC ↗ |
| 89 | Wellington Management ✦ | 13.36M | -8.3% | $14.35B | 2.5% | ▼ Trim | 7 | SEC ↗ |
| 90 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 91 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 92 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 93 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 94 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 95 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 96 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 97 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 98 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 99 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 100 | JPMorgan Chase ✦ | 13.00M | -36.7% | $13.97B | 0.9% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 4,323 Inhaber, 762.84M Anteile, $674.93B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Aug 17
Jonsson Patrik
Officer · 6.50K Ant. · $7.64M
Aug 10
Zakrowski Donald A
Officer · 2.00K Ant. · $2.37M
Aug 07
Hakim Anat
Officer · 5.00K Ant. · $5.95M
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik
Jul 23
SC 13G/A — LILLY ENDOWMENT INC
In den Nachrichten
Aug 24
FDA Clears Roche And Eli Lilly's Alzheimer's Blood Test ↗
The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to help identify…
Forbes
Aug 24
FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly ↗
The Food and Drug Administration cleared a blood test for identifying Alzheimer's disease symptoms, which was developed…
WSJ
Aug 24
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance ↗
The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help identify signs of…
Reuters
Aug 24
Eli Lilly Launches Foundayo Weight-Loss Pill in U.K. ↗
The once-daily pill was approved for patients with a body mass index of at least 30, or between 27 and 30 in the event…
WSJ
Aug 23
Eli Lilly launches oral weight-loss pill Foundayo in UK ↗
Eli Lilly said on Monday it has launched its oral pill, Foundayo, in the UK for weight management and type 2…
Reuters
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q4 2025 ·
Methodik ·
Über die API abrufen